Victoria Serpas Higbie, M.D.
Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2015 | The University of Texas Southwestern Medical School, Dallas, TX, USA, MD, Medicine |
| 2011 | Louisiana State University, Baton Rouge, LA, USA, BS, Biological Sciences |
Postgraduate Training
| 2019-2022 | Clinical Fellowship, Medical Oncology/Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2015-2018 | Clinical Residency, Internal Medicine, Baylor College of Medicine, Houston, TX |
Board Certifications
| 2018 | Internal Medicine |
Honors & Awards
| 2020 | Merit Award Recipient, ASCO GI Cancers Symposium |
| 2018 | Chief Medical Resident, Baylor College of Medicine |
| 2017 | First Place Research Presentation, Texas SE Regional ACP Associate's Day |
| 2016 | Travel Grant, European Society of Medical Oncology |
| 2016 | Best Poster in Category, ESMO Congress |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Stemmer A, Margalit O, Serpas V, Strauss G, Thomas J, Shah P, Tau N, Levanon K, Shacham-Shmueli E, Kopetz S, Overman M, Boursi B. Immunotherapy in mismatch repair-deficient metastatic colorectal cancer - Outcome and novel predictive markers. Eur J Cancer 198:113495, 2024. e-Pub 2023. PMID: 38157568.
- Serpas Higbie V, Rogers J, Hwang H, Qiao W, Xiao L, Dasari A, Mola-Rudd K, Morris VK, Wolff RA, Raghav K, Huey R, Parseghian C, Willis J, Kopetz S, Overman MJ, Johnson B. Antibiotic exposure does not impact immune checkpoint blockade response in MSI-H/dMMR metastatic colorectal cancer: a single center experience. Oncologist 27(11):952-957, 2022. PMID: 35946836.
- Bhamidipati D, Colina A, Hwang H, Wang H, Katz M, Fournier K, Serpas V, Thomas J, Sun R, Wolff RA, Raghav K, Overman MJ.. Metastatic small bowel adenocarcinoma: role of metastasectomy and systemic chemotherapy. ESMO Open 6(3):100132, 2021.
- Serpas VJ, Raghav KP, Halperin DM, Yao J, Overman MJ.. Discrepancies in endpoints between clinical trial protocols and clinical trial registration in randomized trials in oncology. BMC Med Res Methodol 18(1):169, 2018.
Abstracts
- Victoria Serpas, Jane Rogers, Lianchun Xiao, Kerri Rola-Mudd, Arvind Dasari, Bryan Kee, Michael Overman, Benny Johnson. Impact of antibiotic exposure on the efficacy of immune checkpoint blockade in MSI-H metastatic CRC. ASCO Gastrointestinal Cancer Symposium, San Francisco, CA, 2020.
- Victoria Serpas , Kanwal Pratap Singh Raghav, Gauri R. Varadhachary, Robert A. Wolff, Michael J. Overman.. A retrospective study of anti-EGFR antibody therapy in small bowel adenocarcinoma. ASCO 2018 36, 2018.
Patient Reviews
CV information above last modified July 16, 2024